Apple's health team is losing a key top exec

Hello,

Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, back at the helm of this daily newsletter. Today in healthcare news:

• A top Apple Health exec is leaving to join Carbon Health;
• Humana's pouring millions into startups to shape the future of healthcare;
• The 3 things a biotech VC looks for in a startup's presentation.

If you're new to this newsletter, sign up here. Comments, tips? Email me at lramsey@insider.com or tweet @lydiaramsey125. Let's get to it...

A top Apple Health executive is leaving for a startup that's trying to upend primary care for the masses

• Apple's head of strategic bets in healthcare, Myoung Cha, is leaving the company.
• He joined Apple in 2015 to help carve out its health strategy and partnerships.
• Cha is joining Carbon Health, a primary care startup, as president of home-based care and chief strategy officer.

Blake Dodge has the scoop here>>

How health-insurance giant Humana is shaping the future of healthcare by pumping billions into home health and medical clinic companies

• Health insurer Humana is using its cash to shape the future of healthcare outside of hospitals.
• Humana has invested in home-healthcare companies such as DispatchHealth, Heal, and Kindred at Home.
• It's also helping clinic upstarts such as Iora Health, ChenMed, and Oak Street Health expand.

Get the full story>>

Perceptive just raised $515 million to place bets on biotech startups. The fund's manager told us the 3 things he looks for in a startup's pitch.

• Perceptive Advisors just raised a $515 million fund to bet on biotech startups.
• In a crowded biotech investment field, Perceptive wants to stand out by being "entrepreneur friendly."
• One of Perceptive's portfolio managers revealed the myths and facts about what investors look for in a pitch.

Find out what they're looking for>>

More stories we're reading:

• The Biden administration is working with Uber and Lyft to provide free rides to vaccine sites through July 4 (The Wall Street Journal)
• Anti-vaxxers aren't the problem. Why our plan to get the rest of America vaccinated is wrong - and what we should be doing instead. (Insider)
• Ginkgo is officially going public via SPAC in a deal that values the synthetic biology company at $17.5 billion (Bloomberg)
• A 23-year-old Italian woman received 6 times the recommended amount of Pfizer's coronavirus vaccine (Insider)

- Lydia